Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis
Arzu Duran, Şenol Kobak, Nazime Şen, et al.
Bosnian Journal of Basic Medical Sciences (2015)
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Calprotectin in rheumatic diseases
Francesca Ometto, Lara Friso, D. Astorri, et al.
Experimental Biology and Medicine (2016) Vol. 242, Iss. 8, pp. 859-873
Open Access | Times Cited: 146
Recent advances in ankylosing spondylitis: understanding the disease and management
Leticia Garcia‐Montoya, Hanna Gul, Paul Emery
F1000Research (2018) Vol. 7, pp. 1512-1512
Open Access | Times Cited: 126
A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis
Eva Klingberg, Hans Strid, Arne Ståhl, et al.
Arthritis Research & Therapy (2017) Vol. 19, Iss. 1
Open Access | Times Cited: 81
Biomarker development for axial spondyloarthritis
Matthew A. Brown, Zhixiu Li, Kim‐Anh Lê Cao
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 8, pp. 448-463
Closed Access | Times Cited: 46
An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision
Mariagrazia Lorenzin, Francesca Ometto, Augusta Ortolan, et al.
Therapeutic Advances in Musculoskeletal Disease (2020) Vol. 12
Open Access | Times Cited: 40
New thoughts on the gut–immune axis of arthritis
Alexandra Thiran, Lars Vereecke
Trends in Immunology (2025)
Closed Access
Practical Significance of Biomarkers in Axial Spondyloarthritis: Updates on Diagnosis, Disease Activity, and Prognosis
Alexandra-Diana Diaconu, Alexandr Ceasovschih, Victorița Şorodoc, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11561-11561
Open Access | Times Cited: 18
Elevated levels of serum MRP8/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease
Latika Gupta, Shruti Bhattacharya, Vikas Agarwal, et al.
Clinical Rheumatology (2016) Vol. 35, Iss. 12, pp. 3075-3079
Closed Access | Times Cited: 29
Faecal Calprotectin for the Diagnosis of Bowel Inflammation in Patients With Rheumatological Diseases: A Systematic Review
Marine Fauny, Ferdinando D’Amico, Stefanos Bonovas, et al.
Journal of Crohn s and Colitis (2019) Vol. 14, Iss. 5, pp. 688-693
Closed Access | Times Cited: 26
Fecal Calprotectin, Gut Inflammation and Spondyloarthritis
Juliana Simioni, Thelma Larocca Skare, Ana Paula Beckhauser de Campos, et al.
Archives of Medical Research (2019) Vol. 50, Iss. 1, pp. 41-46
Closed Access | Times Cited: 25
Calprotectin in spondyloarthritis: A systematic review and meta-analysis
Yubo Ma, Dazhi Fan, Shanshan Xu, et al.
International Immunopharmacology (2020) Vol. 88, pp. 106948-106948
Closed Access | Times Cited: 23
Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort
Tor Olofsson, Elisabet Lindqvist, Elisabeth Mogård, et al.
Lara D. Veeken (2018) Vol. 58, Iss. 7, pp. 1176-1187
Closed Access | Times Cited: 22
The Role of Fecal Calprotectin in Evaluating Intestinal Involvement of Behçet’s Disease
Burak Özşeker, Cem Şahin, Havva Solak Özşeker, et al.
Disease Markers (2016) Vol. 2016, pp. 1-5
Open Access | Times Cited: 21
Serum calprotectin correlates with risk and disease severity of ankylosing spondylitis and its change during first month might predict favorable response to treatment
Hua Hu, Fei Du, Shizhan Zhang, et al.
Modern Rheumatology (2018) Vol. 29, Iss. 5, pp. 836-842
Open Access | Times Cited: 21
Dynamic changes in gut microbiota under the influence of smoking and TNF-α-blocker in patients with ankylosing spondylitis
Fangze Zhang, Cuili Ma, Bin Zhang, et al.
Clinical Rheumatology (2020) Vol. 39, Iss. 9, pp. 2653-2661
Closed Access | Times Cited: 19
The clinical utility of human leucocyte antigen B27 in axial spondyloarthritis
Chong Seng Edwin Lim, Raj Sengupta, Karl Gaffney
Lara D. Veeken (2017) Vol. 57, Iss. 6, pp. 959-968
Open Access | Times Cited: 20
Association of circulating calprotectin with lipid profile in axial spondyloarthritis
Fernanda Genre, Javier Rueda‐Gotor, Sara Remuzgo‐Martínez, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 15
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs
Devis Benfaremo, Michele Maria Luchetti, Armando Gabrielli
Journal of Immunology Research (2019) Vol. 2019, pp. 1-10
Open Access | Times Cited: 10
Relationship between fecal calprotectin level and disease activity in patients with hidradenitis suppurativa
Emel Eşer, Burhan Engın, Pelin Yüksel, et al.
Dermatologic Therapy (2020) Vol. 33, Iss. 2
Open Access | Times Cited: 10
Selective estrogen receptor modulator lasofoxifene suppresses spondyloarthritis manifestation and affects characteristics of gut microbiota in zymosan-induced SKG mice
Hyemin Jeong, In Young Kim, Eun-Kyung Bae, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Dissecting the Underlying Pharmaceutical Mechanism of Chinese Traditional Medicine Yun-Pi-Yi-Shen-Tong-Du-Tang Acting on Ankylosing Spondylitis through Systems Biology Approaches
Duoli Xie, Lin Huang, Guang‐Hui Zhao, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 8
Fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis
Júlia Faria Campos, Gustavo Gomes Resende, Alfredo José Afonso Barbosa, et al.
International Journal of Rheumatic Diseases (2022) Vol. 25, Iss. 9, pp. 1078-1086
Closed Access | Times Cited: 5
Approach to the Patient with Axial Spondyloarthritis and Suspected Inflammatory Bowel Disease
Sebastián Ibañez, María Paz Poblete De La Fuente, Elisa Catalina Parra Cancino
Rheumatic Disease Clinics of North America (2020) Vol. 46, Iss. 2, pp. 275-286
Closed Access | Times Cited: 4
Investigation of asymptomatic intestinal inflammation in ankylosing spondylitis by fecal calprotectin
Cem Erçalık, Mehmet Çetin Başkaya, Sebahat Özdem, et al.
Arab Journal of Gastroenterology (2021) Vol. 22, Iss. 4, pp. 272-277
Closed Access | Times Cited: 4
Elevated type-17 cytokines are present in axial spondyloarthritis stool
India Brough, Kelsey Thompson, Ciara Latore, et al.
Discovery Immunology (2024) Vol. 3, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top